Dr. Jennifer Cross is an immunologist with nearly 10 years of experience in preclinical drug discovery and development. Most recently, Jennifer worked for Aquinox Pharmaceuticals, helping to drive the discovery and development of novel compounds in the areas of inflammation, pain, and oncology through IND-enabling studies. Jennifer also has experience with supporting early-phase clinical studies, contributing to both IND and NDA regulatory submissions, and is an author on 18 peer-reviewed scientific publications. Jennifer obtained her PhD in Immunology from the University of British Columbia.
